Xcout Intel
Kamari Pharma
Kamari Pharma (now Orvida Pharma) is a privately held biopharmaceutical company located at the Weizmann Science Park in Ness Ziona, Israel, focused on developing therapeutic treatments.
Subscribe to see Kamari Pharma’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Kamari Pharma at a glance
Kamari Pharma is a pharmaceuticals company headquartered in Israel. Its most recent funding round, Series A, raised $23M in June 2025. Xcout tracks 10 named people at Kamari Pharma, including David Aviezer (CEO).
Kamari Pharma leadership
- David AviezerCEO
- Asaf YarkoniChief Finance Officer
- Einat Brill AlmonChief Regulatory Officer
- Liora BraimanChief Scientific Officer
- Dayana MichelSVP Medical & Clinical Affairs
- Myriam GolemboSVP Regulatory and Strategy Affairs
4 more named people on record for Kamari Pharma, with roles, board committees and tenure — see the full roster →
Kamari Pharma funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $23M | 10 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Kamari Pharma competitors
A few of Kamari Pharma's closest competitors — see the full list of competitors and alternatives →
Wize Pharma, Inc. is a clinical-stage biopharmaceutical company headquartered in Hod Hasharon, Israel. The company focuses on the development and commercialization of treatments for ophthalmic and other serious medical conditions.
Kamada Ltd. is a biopharmaceutical firm focused on developing, manufacturing, and distributing protein therapeutics derived from human plasma. The company operates through two core business areas: its proprietary product segment and its distribution division. Its own manufactured portfolio includes KAMRAB/KEDRAB for rabies prevention, CYTOGAM to prevent cytomegalovirus disease in transplant recipients, WINRHO SDF for immune thrombocytopenic purpura and Rhesus (Rh) isoimmunization, HEPAGAM B for hepatitis B recurrence prevention following liver transplants and for post-exposure prophylaxis, VARIZIG for post-exposure chickenpox prophylaxis, and GLASSIA for intravenous alpha-1 antitrypsin deficiency (AATD). Kamada also produces KamRho (D) for the prophylaxis of hemolytic disease of newborns and immune thrombocytopenic purpura, along with a specific antiserum for Vipera palaestinae and Echis coloratus snake bites. Additionally, the company distributes a wide array of third-party pharmaceutical products, encompassing treatments like BRAMITOB for chronic pulmonary infections, FOSTER for asthma, PROVOCHOLINE for diagnosing bronchial airway hyperactivity, and specialized therapies such as IVIG for immunodeficiency, VARITECT for chickenpox and zoster herpes, and various factors for hemophilia A and B, among numerous others for conditions like hepatitis B, cytomegalovirus, angioedema, Japanese encephalitis, and prostate cancer. Kamada markets its offerings in the United States through strategic partners and internationally via a network of distributors. The company maintains significant collaborations with Takeda Pharmaceuticals Company Limited, PARI GmbH, and Kedrion Biopharma. Established in 1990, Kamada Ltd. is headquartered in Rehovot, Israel.
RDD Pharma Ltd. is a biopharmaceutical company focused on the discovery and development of therapeutic products for gastrointestinal and anorectal diseases. Headquartered in Israel with locations in Tel Aviv and Ofakim, the company specializes in targeted treatments.
Abital Pharma is an Israeli therapeutics company founded in 2012 by Prof. Moussa B. H. Youdim, focusing on the development of original drugs and operating as a life science incubator.
Pharma Two B Ltd. is a late-clinical stage biopharmaceutical company headquartered in Kiryat Ono, Israel. The company focuses on developing pharmaceutical treatments and therapeutic products for neurological and related medical conditions. It has pursued corporate growth initiatives, including planned public market transactions via mergers.
Kashiv BioSciences is a vertically integrated biopharmaceutical company with global R&D, clinical, manufacturing, regulatory, and IP capabilities, maintaining its headquarters in Bridgewater, New Jersey.
Get Kamari Pharma's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Kamari Pharma in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access